Product Information

METHYLPHENIDATE ER(CD) 30 MG CP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.8067 per EA under NDC 00115173801. Its NADAC has been published 440 times since Jun 13, 2018.

FDA first approved this application on Jul 28, 2016. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER(CD) 30 MG CP

Methylphenidate Hydrochloride
$1.8067per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00115173801

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205105

FDA Approved

7/28/2016

TE Code

AB2

On Market Since

9/20/2016

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER(CD) 30 MG CP has been published 440 times since Jun 13, 2018, and over the history we have for it it has declined 45.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8067 per EA
All-time high$3.3188 (Jun 13, 2018)
All-time low$0.9240 (Jul 17, 2024)
52-week high$1.9151
52-week low$1.7332
Median price$1.7518
Average price$1.8374
Largest weekly change+58.7% (Jun 19, 2024)
Weeks tracked440
Tracking sinceJun 13, 2018

Price History

1W

0.0%

1M

+0.7%

3M

-1.6%

6M

+3.1%

1Y

+1.4%

3Y

+37.1%

5Y

+54.5%

All

-45.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER(CD) 30 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(CD) 30 MG CP, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.8067 per EA (NDC 00115173801), effective Nov 11, 2026.

How has the price of METHYLPHENIDATE ER(CD) 30 MG CP changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER(CD) 30 MG CP has declined 45.6%. It has been tracked across 440 weekly CMS publications since Jun 13, 2018.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(CD) 30 MG CP?

Since Jun 13, 2018, the NADAC for METHYLPHENIDATE ER(CD) 30 MG CP has ranged from a low of $0.9240 (Jul 17, 2024) to a high of $3.3188 (Jun 13, 2018), with a median of $1.7518 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER(CD) 30 MG CP?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER(LA) 30 MG CP, is $1.7188 per EA — about 5% below METHYLPHENIDATE ER(CD) 30 MG CP.

Who manufactures METHYLPHENIDATE ER(CD) 30 MG CP?

METHYLPHENIDATE ER(CD) 30 MG CP (NDC 00115173801) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.